Another Perspective on Cardio-Oncology: Insights from Houston, Texas

1. Riaz MH, Barrington C, Ionescu A. A minimalist cardio-oncology service: A personal experience from Wales. Romanian Journal of Cardiology. 2024;34(4):161-164. https://doi.org/10.2478/rjc-2024-0018 Riaz MH Barrington C Ionescu A. A minimalist cardio-oncology service: A personal experience from Wales . Romanian Journal of Cardiology . 2024 ; 34 ( 4 ): 161 – 164 . https://doi.org/10.2478/rjc-2024-0018 Search in Google Scholar

2. Ainger LE, Bushore J, Johnson WW, Ito J. Daunomycin: a cardiotoxic agent. J Natl Med Assoc. 1971;63(4):261–7. Ainger LE Bushore J Johnson WW Ito J. Daunomycin: a cardiotoxic agent . J Natl Med Assoc . 1971 ; 63 ( 4 ): 261 – 7 . Search in Google Scholar

3. Ali MK, Kahlil KG, Fuller LM, et al. Radiation-related myocardial injury. Management of two cases. Cancer. 1976;38(5):1941–6. Ali MK Kahlil KG Fuller LM et al. Radiation-related myocardial injury . Management of two cases. Cancer . 1976 ; 38 ( 5 ): 1941 – 6 . Search in Google Scholar

4. Henderson IC, Sloss LJ, Jaffe N, Blum RH, Frei E 3rd. Serial studies of cardiac function in patients receiving adriamycin. Cancer Treat Rep. 1978;62(6):923–9. Henderson IC Sloss LJ Jaffe N Blum RH Frei E 3rd. Serial studies of cardiac function in patients receiving adriamycin . Cancer Treat Rep . 1978 ; 62 ( 6 ): 923 – 9 . Search in Google Scholar

5. Cardinale D. [A new frontier: cardio-oncology]. Cardiologia. 1996;41(9):887–91. Cardinale D. [A new frontier: cardio-oncology] . Cardiologia . 1996 ; 41 ( 9 ): 887 – 91 . Search in Google Scholar

6. Kerkelä R, Grazette L, Yacobi R, et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med. 2006;12(8):908–16. Kerkelä R Grazette L Yacobi R et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate . Nat Med . 2006 ; 12 ( 8 ): 908 – 16 . Search in Google Scholar

7. Yeh ET. Onco-cardiology: the time has come. Tex Heart Inst J. 2011;38(3):246–7. Yeh ET. Onco-cardiology: the time has come . Tex Heart Inst J . 2011 ; 38 ( 3 ): 246 – 7 . Search in Google Scholar

8. Iliescu C, Durand JB, Kroll M. Cardiovascular interventions in thrombocytopenic cancer patients. Tex Heart Inst J. 2011;38(3):259–60. Iliescu C Durand JB Kroll M. Cardiovascular interventions in thrombocytopenic cancer patients . Tex Heart Inst J . 2011 ; 38 ( 3 ): 259 – 60 . Search in Google Scholar

9. Lenihan DJ, Cardinale D, Cipolla CM. The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society. Prog Cardiovasc Dis. 2010;53(2):88–93. Lenihan DJ Cardinale D Cipolla CM. The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society . Prog Cardiovasc Dis . 2010 ; 53 ( 2 ): 88 – 93 . Search in Google Scholar

10. Barac A, Murtagh G, Carver JR, et al. Cardiovascular health of patients with cancer and cancer survivors: A roadmap to the next level. J Am Coll Cardiol. 2015;65(25):2739–46. Barac A Murtagh G Carver JR et al. Cardiovascular health of patients with cancer and cancer survivors: A roadmap to the next level . J Am Coll Cardiol . 2015 ; 65 ( 25 ): 2739 – 46 . Search in Google Scholar

11. Iliescu CA, Grines CL, Herrmann J, et al. SCAI expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2016;87(5):E202–23. Iliescu CA Grines CL Herrmann J et al. SCAI expert consensus statement: Evaluation, management, and special considerations of cardiooncology patients in the cardiac catheterization laboratory . Catheter Cardiovasc Interv . 2016 ; 87 ( 5 ): E202 – 23 . Search in Google Scholar

12. Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27(9):911–39. Plana JC Galderisi M Barac A et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging . J Am Soc Echocardiogr . 2014 ; 27 ( 9 ): 911 – 39 . Search in Google Scholar

13. Lopez-Mattei J, Yang EH, Baldassarre LA, et al. Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS). J Cardiovasc Comput Tomogr. 2023;17(1):66–83. Lopez-Mattei J Yang EH Baldassarre LA et al. Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT) . Endorsed by the International Cardio-Oncology Society (ICOS). J Cardiovasc Comput Tomogr . 2023 ; 17 ( 1 ): 66 – 83 . Search in Google Scholar

14. Yusuf SW, Daraban N, Abbasi N, Lei X, Durand JB, Daher IN. Treatment and outcomes of acute coronary syndrome in the cancer population. Clin Cardiol. 2012;35(7):443–50. Yusuf SW Daraban N Abbasi N Lei X Durand JB Daher IN. Treatment and outcomes of acute coronary syndrome in the cancer population . Clin Cardiol . 2012 ; 35 ( 7 ): 443 – 50 . Search in Google Scholar

15. Wilson NR, Lee MT, Gill CD, et al. Prognostic factors and overall survival after pericardiocentesis in patients with cancer and thrombocytopenia. Front Cardiovasc Med. 2021;8:638943. Wilson NR Lee MT Gill CD et al. Prognostic factors and overall survival after pericardiocentesis in patients with cancer and thrombocytopenia . Front Cardiovasc Med . 2021 ; 8 : 638943 . Search in Google Scholar

16. Yusuf SW, Iliescu C, Bathina JD, Daher IN, Durand JB. Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia. Tex Heart Inst J. 2010;37(3):336–40. Yusuf SW Iliescu C Bathina JD Daher IN Durand JB. Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia . Tex Heart Inst J . 2010 ; 37 ( 3 ): 336 – 40 . Search in Google Scholar

17. Schechter M, Balanescu DV, Donisan T, et al. An update on the management and outcomes of cancer patients with severe aortic stenosis. Catheter Cardiovasc Interv. 2019;94(3):438–45. Schechter M Balanescu DV Donisan T et al. An update on the management and outcomes of cancer patients with severe aortic stenosis . Catheter Cardiovasc Interv . 2019 ; 94 ( 3 ): 438 – 45 . Search in Google Scholar

18. Yusuf SW, Sarfaraz A, Durand JB, Swafford J, Daher IN. Management and outcomes of severe aortic stenosis in cancer patients. Am Heart J. 2011;161(6):1125–32. Yusuf SW Sarfaraz A Durand JB Swafford J Daher IN. Management and outcomes of severe aortic stenosis in cancer patients . Am Heart J . 2011 ; 161 ( 6 ): 1125 – 32 . Search in Google Scholar

19. Balanescu SM, Balanescu DV, Donisan T, et al. The onco-cardiologist dilemma: To implant, to defer, or to avoid transcatheter aortic valve replacement in cancer patients with aortic stenosis? Curr Cardiol Rep. 2019;21(8):83. Balanescu SM Balanescu DV Donisan T et al. The onco-cardiologist dilemma: To implant, to defer, or to avoid transcatheter aortic valve replacement in cancer patients with aortic stenosis? Curr Cardiol Rep . 2019 ; 21 ( 8 ): 83 . Search in Google Scholar

20. Gill C, Lee M, Balanescu DV, et al. Transcatheter and surgical aortic valve replacement impact on outcomes and cancer treatment schedule. Int J Cardiol. 2021;326:62–70. Gill C Lee M Balanescu DV et al. Transcatheter and surgical aortic valve replacement impact on outcomes and cancer treatment schedule . Int J Cardiol . 2021 ; 326 : 62 – 70 . Search in Google Scholar

21. Thomason N, Monlezun DJ, Javaid A, et al. Percutaneous coronary intervention in patients with gynecological cancer: Machine learning-augmented propensity score mortality and cost analysis for 383,760 patients. Front Cardiovasc Med. 2021;8:793877. Thomason N Monlezun DJ Javaid A et al. Percutaneous coronary intervention in patients with gynecological cancer: Machine learning-augmented propensity score mortality and cost analysis for 383,760 patients . Front Cardiovasc Med . 2021 ; 8 : 793877 . Search in Google Scholar

22. Marmagkiolis K, Monlezun DJ, Caballero J, et al. Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures. Int J Cardiol. 2024;408:132091. Marmagkiolis K Monlezun DJ Caballero J et al. Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures . Int J Cardiol . 2024 ; 408 : 132091 . Search in Google Scholar

23. Pushparaji B, Donisan T, Balanescu DV, et al. Interventional strategies in cancer-induced cardiovascular disease. Curr Oncol Rep. 2021;23(11):133. Pushparaji B Donisan T Balanescu DV et al. Interventional strategies in cancer-induced cardiovascular disease . Curr Oncol Rep . 2021 ; 23 ( 11 ): 133 . Search in Google Scholar

24. Chauhan S, Monlezun DJ, Kim JW, et al. Fractional flow reserve cardio-oncology effects on inpatient mortality, length of stay, and cost based on malignancy type: Machine learning supported nationally representative casecontrol study of 30 million hospitalizations. Medicina (Kaunas). 2022;58(7). Chauhan S Monlezun DJ Kim JW et al. Fractional flow reserve cardiooncology effects on inpatient mortality, length of stay, and cost based on malignancy type: Machine learning supported nationally representative case-control study of 30 million hospitalizations . Medicina (Kaunas) . 2022 ; 58 ( 7 ). Search in Google Scholar

25. Kim JW, Dayah TJ, Javaid A, et al. Reclassification of treatment strategy with fractional flow reserve in cancer patients with coronary artery disease. Medicina (Kaunas). 2022;58(7). Kim JW Dayah TJ Javaid A et al. Reclassification of treatment strategy with fractional flow reserve in cancer patients with coronary artery disease . Medicina (Kaunas) . 2022 ; 58 ( 7 ). Search in Google Scholar

26. Iliescu CA, Cilingiroglu M, Giza DE, et al. “Bringing on the light” in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry). Am Heart J. 2017;194:83–91. Iliescu CA Cilingiroglu M Giza DE et al. “Bringing on the light” in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry) . Am Heart J . 2017 ; 194 : 83 – 91 . Search in Google Scholar

27. Honan KA, Hassan S, Deswal A, et al. Bioprosthetic valve monitoring in patients with carcinoid heart disease. Front Cardiovasc Med. 2022;9:1072890. Honan KA Hassan S Deswal A et al. Bioprosthetic valve monitoring in patients with carcinoid heart disease . Front Cardiovasc Med . 2022 ; 9 : 1072890 . Search in Google Scholar

28. Monlezun DJ, Badalamenti A, Javaid A, et al. Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve”. Front Cardiovasc Med. 2022;9:1071138. Monlezun DJ Badalamenti A Javaid A et al. Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve” . Front Cardiovasc Med . 2022 ; 9 : 1071138 . Search in Google Scholar

29. Ahmed T, Marmagkiolis K, Ploch M, et al. The year in cardio-oncology 2022. Curr Probl Cardiol. 2023;48(1):101435. Ahmed T Marmagkiolis K Ploch M et al. The year in cardio-oncology 2022 . Curr Probl Cardiol . 2023 ; 48 ( 1 ): 101435 . Search in Google Scholar